Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda like polypeptide 3, pseudogene (IGLL3P), is a non-functional pseudogene located in the human immunoglobulin lambda locus on chromosome 22[5][1]. Pseudogenes like IGLL3P are defective copies of protein-coding genes that have lost their protein-coding potential, typically as a result of gene duplication or retrotransposition followed by disrupting mutations[4][6]. While a minority of pseudogenes show regulatory activity or are transcribed, IGLL3P is not currently established as functionally relevant and does not encode a known polypeptide. It is primarily used as a reference in genomic and evolutionary studies of the immunoglobulin lambda light chain loci, but it is not considered a functional receptor, enzyme, transporter, or classic drug target[1][5][3].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda like polypeptide 3, pseudogene (IGLL3P).